- Home
- ONVO vs NUWE Comparison
ONVO vs NUWE Comparison
Compare ONVO & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONVO
- NUWE
- Stock Information
- Founded
- ONVO 2007
- NUWE 1999
- Country
- ONVO United States
- NUWE United States
- Employees
- ONVO N/A
- NUWE N/A
- Industry
- ONVO Biotechnology: Biological Products (No Diagnostic Substances)
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ONVO Health Care
- NUWE Health Care
- Exchange
- ONVO Nasdaq
- NUWE Nasdaq
- Market Cap
- ONVO 5.3M
- NUWE 5.2M
- IPO Year
- ONVO N/A
- NUWE N/A
- Fundamental
- Price
- ONVO $0.37
- NUWE $1.30
- Analyst Decision
- ONVO
- NUWE Strong Buy
- Analyst Count
- ONVO 0
- NUWE 1
- Target Price
- ONVO N/A
- NUWE $17.00
- AVG Volume (30 Days)
- ONVO 103.2K
- NUWE 1.1M
- Earning Date
- ONVO 02-19-2025
- NUWE 03-11-2025
- Dividend Yield
- ONVO N/A
- NUWE N/A
- EPS Growth
- ONVO N/A
- NUWE N/A
- EPS
- ONVO N/A
- NUWE N/A
- Revenue
- ONVO $122,000.00
- NUWE $8,969,000.00
- Revenue This Year
- ONVO $59.08
- NUWE $2.18
- Revenue Next Year
- ONVO $18.24
- NUWE $25.75
- P/E Ratio
- ONVO N/A
- NUWE N/A
- Revenue Growth
- ONVO N/A
- NUWE 3.66
- 52 Week Low
- ONVO $0.32
- NUWE $0.92
- 52 Week High
- ONVO $1.74
- NUWE $26.95
- Technical
- Relative Strength Index (RSI)
- ONVO 49.60
- NUWE 52.78
- Support Level
- ONVO $0.33
- NUWE $1.17
- Resistance Level
- ONVO $0.40
- NUWE $1.48
- Average True Range (ATR)
- ONVO 0.03
- NUWE 0.09
- MACD
- ONVO 0.00
- NUWE 0.01
- Stochastic Oscillator
- ONVO 61.25
- NUWE 45.45
About ONVO Organovo Holdings Inc.
Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical device company. Its solutions includes Aquadex Smartflow System and RenalSense Clarity RMS. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Clarity RMS is a kidney monitoring system that continuously measures urine output and flows, automatically displaying real-time data to the medical staff.